Back to UBS Group AG UBS Group AG

VIVOVIVO

Showing 0 of 17 quarters

Position history for UBS Group AGUBS Group AG's holdings in MERIDIAN BIOSCIENCE INC

As of its Q4 2022 13F, UBS Group held 50,739 shares of VIVO (Meridian Bioscience), worth $1.7M. UBS Group's 13F filings listed VIVO from Q1 2019 to Q4 2022, 16 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used